Alkermes
ALKS
#3093
Rank
C$6.73 B
Marketcap
C$40.78
Share price
0.75%
Change (1 day)
-6.75%
Change (1 year)

Alkermes (ALKS) - Net assets

Net assets on the balance sheet as of September 2025 : C$2.39 Billion

According to Alkermes's latest financial reports the company has C$2.39 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alkermes - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$2.10 B31.79%
2023-12-31$C$1.59 B12.63%
2022-12-31$C$1.41 B-0.11%
2021-12-31$C$1.41 B4.22%
2020-12-31$C$1.36 B-4.03%
2019-12-31$C$1.41 B-11.15%
2018-12-31$C$1.59 B5.51%
2017-12-31$C$1.51 B-6.96%
2016-12-31$C$1.62 B-10.85%
2015-12-31$C$1.82 B12.47%
2014-12-31$C$1.62 B
2013-03-31$C$0.96 B13.6%
2012-03-31$C$0.85 B124.3%
2011-03-31$C$0.38 B-8.63%
2010-03-31$C$0.41 B-23.95%
2009-03-31$C$0.54 B76.65%
2008-03-31$C$0.30 B31.49%
2007-03-31$C$0.23 B502.65%
2006-03-31$C$39.07 M683.24%
2005-03-31$C$4.98 M-94.97%
2004-03-31$C$99.26 M-1439.3%
2003-03-31$-C$7.42 Million-104.66%
2002-03-31$C$0.15 B-32.11%
2001-03-31$C$0.23 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Acorda Therapeutics
ACOR
-C$0.26 Billion-110.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$25.69 B 973.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$109.52 B 4,473.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$128.61 B 5,270.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$63.50 B 2,552.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$10.02 B 318.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
C$119.21 B 4,878.41%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
C$61.82 B 2,481.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland